Advertisement
Anesthesiology and Pulmonary Medicine
Subscribe to Anesthesiology and Pulmonary Medicine
View Sample

FREE Email Newsletter

Power Wheelchairs Keep Medicare Beneficiaries Out of Nursing Homes, While Reducing Government Costs and Providing More Freedom and Independence

May 5, 2011 2:32 pm | by Bio-Medicine.Org | News | Comments

OCEANSIDE, Calif., May 5, 2011 /PRNewswire-USNewswire/ -- For Judith Talnadge, a power wheelchair provided through Medicare is the difference between living independently in her apartment, with opportunities to visit with friends and engage in the community, or being confined to a nursing...

Pearl Therapeutics Highlights Its Porous Particle Cosuspension Platform, Demonstrating Universal Applicability Across Multiple Drug Classes and Combination Products

May 5, 2011 6:37 am | by Bio-Medicine.Org | News | Comments

REDWOOD CITY, Calif., May 5, 2011 /- Pearl Therapeutics Inc. made three presentations at the Respiratory Drug Delivery Europe (RDD Europe 2011) meeting in Berlin this week elucidating the tunability, versatility and universality of the Company's porous particle-based metered dose inhaler...

New algorithm significantly improves imaging for full-body MRIs

May 4, 2011 10:37 pm | by EurekAlert | News | Comments

(American Roentgen Ray Society) A new study reveals an improved algorithm that can dramatically improve how radiologists capture and interpret full-body MRIs, particularly in the abdominal region.

Advertisement

Aires Pharmaceuticals Appoints Edwin L. Parsley as Chief Medical Officer

May 4, 2011 8:40 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, May 4, 2011 /- Aires Pharmaceuticals, Inc. today announced the hiring of Ed Parsley, D.O. as Chief Medical Officer.  Dr. Parsley will fill a key role on Aires' leadership team and will be responsible for all clinical development activities for Aironite™, the...

Plato BioPharma Presenting Poster at the American Thoracic Society Conference

May 4, 2011 8:40 am | by Bio-Medicine.Org | News | Comments

WESTMINSTER, Colo., May 4, 2011 /- Plato BioPharma, Inc. (PBI) and Gilead Sciences, Inc. will be jointly presenting a thematic poster at the "Novel Therapeutics in Pulmonary Fibrosis" session at the 2011 American Thoracic Society (ATS) International Conference in Denver, Colorado on May...

Delay of Medicare Bidding Program for Home Medical Equipment Underscores Severe Problems with Program; Support Surges for Bipartisan Bill to Repeal the Bid Program

May 4, 2011 8:40 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, May 4, 2011 /PRNewswire-USNewswire/ -- The delay in round two of Medicare's controversial "competitive" bidding program for home medical equipment and services underscores that program's severe design flaws. Opposition to the program continues to build among patient and...

Via Oncology Pathways Now Incorporate Advance Care Planning Decision Support

May 4, 2011 8:40 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, May 4, 2011 /- The most recent release of Via Oncology Pathways from D3 Oncology Solutions (D3) now includes decision support for advance care planning to encourage early discussions between oncologists and their patients about the disease, treatment intent and likely...

GenVec to Host First Quarter 2011 Earnings Call and Webcast

May 3, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

GAITHERSBURG, Md., May 3, 2011 /- GenVec, Inc. (Nasdaq: GNVCD) announced that it will release financial results for the first quarter ended March 31, 2011 on Monday, May 9, 2011 after market close.  GenVec will hold a conference call at 10:00 a.m. EDT on Tuesday, May 10, 2011 to...

Advertisement

Phreesia Helps Practices Manage Patients with Uncontrolled Asthma

May 3, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

NEW YORK, May 3, 2011 /- Phreesia, the patient check-in company, announced the release of an asthma control assessment to all primary care physicians and pediatrics practices in its network. The screening tool is part of Phreesia's automated patient check-in solution and, through a series...

Boston Scientific Announces CE Mark Approval and First Use of Blazerâ„¢ Open-Irrigated Catheter in Europe

May 3, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

NATICK, Mass., May 3, 2011 /- Boston Scientific Corporation (NYSE: BSX ) today announced CE Mark approval and first use in Europe of its Blazer™ Open-Irrigated Catheter, the Company's latest radiofrequency ablation (RFA) catheter designed to treat a variety of arrhythmias such as...

GenerationOne Selected by Cincinnati Children's Hospital Medical Center for Mobile Health Pilot with Teen Asthmatics

May 3, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

MIAMI, May 3, 2011 /- GenerationOne and Cincinnati Children's Hospital Medical Center collaborated on a 14-month clinical trial for testing mobile technology in aiding the management of teenagers with Asthma. "Mobile phones represent an appealing technology for tailoring interventions and...

Generex Biotechnology Corporation CEO to Present Live, Online at RetailInvestorConferences.com on May 5th

May 2, 2011 9:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, May 2, 2011 /- Generex Biotechnology Corporation ( www.generex.com ) (OTC: GNBT) today announced that Mark Fletcher, CEO, will present at RetailInvestorConferences.com. DATE: May 5th, 2011 TIME:  11:00 AM EDT LINK: www.retailinvestorconferences.com >Click the red...

SeraCare renews $17M federal research-support contract

May 2, 2011 7:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

SeraCare Life Sciences Inc., a Milford provider of products and services that support drug discovery and medical device development, has won a contract renewal, worth about $17.6 million over five years, from the National Heart, Lung, and Blood Institute of the National Institutes of Health.

Advertisement

Proton imaging provides more accuracy, less radiation to pediatric cancer patients

April 29, 2011 5:33 am | by EurekAlert | News | Comments

(American Society for Radiation Oncology) Proton radiography imaging used prior to and during proton treatments for pediatric cancer patients provides for more accurate treatment delivery and a lower dose of radiation compared to standard diagnostic X-rays and cone beam CT, according to a...

Measles outbreak underscores need for continued vigilance in health care settings

April 28, 2011 8:35 pm | by EurekAlert | News | Comments

(Infectious Diseases Society of America) In 2008, the largest reported health care-associated measles outbreak in the United States since 1989 occurred in Tucson, Ariz., costing approximately $800,000 in response and containment efforts. In a report published in The Journal of Infectious...

Frequently hospitalized patients may benefit from new medical specialty focused on their needs

April 28, 2011 8:35 pm | by EurekAlert | News | Comments

(University of Chicago) Declining rates of hospitalization have discouraged primary care doctors from seeing their patients in the hospital and encouraged the growing use of "hospitalists," a new physician specialty focused on the care of hospitalized patients. Further developments in the...

Use of costly breast cancer therapy strongly influenced by reimbursement policy

April 28, 2011 11:33 am | by EurekAlert | News | Comments

(Journal of the National Cancer Institute) What Medicare would pay for and where a radiation oncologist practiced were two factors that strongly influenced the choice of intensity-modulated radiation therapy (IMRT) for treating breast cancer, according to an article published April 29...

MAQUET Cardiovascular Receives 510(k) Clearance to Market the CARDIOHELP System in U.S.

April 28, 2011 6:35 am | by Bio-Medicine.Org | News | Comments

WAYNE, N.J., April 28, 2011 /- MAQUET Cardiovascular today announced that the U.S. Food and Drug Administration has granted the company 510(k) clearance to market its CARDIOHELP System in the United States as a cardiac and/or respiratory assist device for up to six hours.  The...

International Leaders in Electrophysiology Discuss Improving Atrial Fibrillation Treatment Using Novel Endoscopically Guided Laser Ablation Catheter

April 28, 2011 2:33 am | by Bio-Medicine.Org | News | Comments

MARLBOROUGH, Mass., April 28, 2011 /- CardioFocus, Inc., developer of the Endoscopic Ablation System for the transcatheter treatment of Atrial Fibrillation (AF), convened international leaders in electrophysiology to discuss the advantages of direct optical visualization to guide catheter...

Large differences in mortality between urban and isolated rural areas

April 27, 2011 11:34 am | by EurekAlert | News | Comments

(Norwegian Institute of Public Health) In urban communities, less than 1 in 100 inhabitants died from Spanish flu in 1918, but in isolated communities up to 9 out of 10 died. This could be due to different exposure to influenza in the decades before Spanish flu. People in urban...

Less than One-Third of Patients Taking Montelukast (Singulair®) Therapy for Asthma or Allergies without Trying First-Line Medications End Up Staying on the Medication

April 27, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

ST. PAUL, Minn., April 27, 2011 /- Patients with asthma or allergic rhinitis (nasal allergies), initially prescribed montelukast (Singulair®) instead of typical first-line therapy have low rates of persistence on montelukast and may ultimately discontinue therapy altogether,...

Advanced Life Sciences Ticker Symbol Reverts Back to 'ADLS.OB'

April 27, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

CHICAGO, April 27, 2011 /- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS.OB) , a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced that...

Reportlinker Adds Global Cardiovascular Surgery Devices Market Trends and Future Forecast (2009 - 2014)

April 27, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, April 27, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Cardiovascular Surgery Devices Market Trends and Future Forecast (2009 - 2014)...

Dehaier Medical to Report First Quarter 2011 Financial Results on May 4

April 27, 2011 3:34 am | by Bio-Medicine.Org | News | Comments

BEIJING, April 27, 2011 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM ) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it will...

Renewable Fuel Standard Provides Market Space and Predictable Price for Advanced Biofuels

April 26, 2011 5:34 pm | by Biotechnology Industry Organization | News | Comments

WASHINGTON, D.C. (Tuesday, April 19, 2011) - The federal Renewable Fuel Standard provides the stable market support and pricing system necessary to attract private investment to the development of advanced biofuels, according to a new policy white paper published by the Biotechnology...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading